nodes	percent_of_prediction	percent_of_DWPC	metapath
Desloratadine—ABCB1—kidney cancer	0.265	1	CbGaD
Desloratadine—ABCB1—Temsirolimus—kidney cancer	0.0546	0.1	CbGbCtD
Desloratadine—CYP2D6—Temsirolimus—kidney cancer	0.0514	0.0946	CbGbCtD
Desloratadine—CYP1A2—Pazopanib—kidney cancer	0.0328	0.0603	CbGbCtD
Desloratadine—CYP2C9—Capecitabine—kidney cancer	0.0308	0.0567	CbGbCtD
Desloratadine—ABCB1—Pazopanib—kidney cancer	0.0287	0.0527	CbGbCtD
Desloratadine—CYP2D6—Pazopanib—kidney cancer	0.027	0.0497	CbGbCtD
Desloratadine—ABCB1—Dactinomycin—kidney cancer	0.0262	0.0482	CbGbCtD
Desloratadine—CYP1A2—Erlotinib—kidney cancer	0.0234	0.043	CbGbCtD
Desloratadine—ABCB1—Gemcitabine—kidney cancer	0.0207	0.0381	CbGbCtD
Desloratadine—CYP2C19—Sorafenib—kidney cancer	0.0206	0.0379	CbGbCtD
Desloratadine—ABCB1—Erlotinib—kidney cancer	0.0205	0.0376	CbGbCtD
Desloratadine—CYP2C9—Paclitaxel—kidney cancer	0.0193	0.0355	CbGbCtD
Desloratadine—CYP2D6—Erlotinib—kidney cancer	0.0193	0.0355	CbGbCtD
Desloratadine—CYP1A2—Sorafenib—kidney cancer	0.019	0.035	CbGbCtD
Desloratadine—ABCB1—Paclitaxel—kidney cancer	0.0187	0.0345	CbGbCtD
Desloratadine—CYP2C9—Sorafenib—kidney cancer	0.0171	0.0315	CbGbCtD
Desloratadine—ABCB1—Sorafenib—kidney cancer	0.0166	0.0306	CbGbCtD
Desloratadine—ABCB1—Vinblastine—kidney cancer	0.0164	0.0302	CbGbCtD
Desloratadine—ABCB1—Vincristine—kidney cancer	0.0161	0.0297	CbGbCtD
Desloratadine—CYP2D6—Sorafenib—kidney cancer	0.0157	0.0288	CbGbCtD
Desloratadine—CYP2D6—Vinblastine—kidney cancer	0.0155	0.0285	CbGbCtD
Desloratadine—ABCB1—Sunitinib—kidney cancer	0.0135	0.0248	CbGbCtD
Desloratadine—ABCB1—Doxorubicin—kidney cancer	0.0101	0.0186	CbGbCtD
Desloratadine—CYP2D6—Doxorubicin—kidney cancer	0.00951	0.0175	CbGbCtD
Desloratadine—CYP2C19—urine—kidney cancer	0.000469	0.241	CbGeAlD
Desloratadine—CYP1A2—urine—kidney cancer	0.000383	0.197	CbGeAlD
Desloratadine—CYP2C9—urine—kidney cancer	0.000364	0.187	CbGeAlD
Desloratadine—Convulsion—Vincristine—kidney cancer	0.000281	0.00157	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000281	0.00157	CcSEcCtD
Desloratadine—Fatigue—Sorafenib—kidney cancer	0.000281	0.00157	CcSEcCtD
Desloratadine—Dyspnoea—Sunitinib—kidney cancer	0.000279	0.00156	CcSEcCtD
Desloratadine—Hypersensitivity—Vinblastine—kidney cancer	0.000278	0.00155	CcSEcCtD
Desloratadine—Myalgia—Vincristine—kidney cancer	0.000277	0.00154	CcSEcCtD
Desloratadine—Hypersensitivity—Everolimus—kidney cancer	0.000276	0.00154	CcSEcCtD
Desloratadine—Dyspepsia—Sunitinib—kidney cancer	0.000276	0.00154	CcSEcCtD
Desloratadine—Cardiac disorder—Paclitaxel—kidney cancer	0.000275	0.00153	CcSEcCtD
Desloratadine—CYP2D6—urine—kidney cancer	0.000273	0.14	CbGeAlD
Desloratadine—Decreased appetite—Sunitinib—kidney cancer	0.000272	0.00152	CcSEcCtD
Desloratadine—Infestation NOS—Capecitabine—kidney cancer	0.000271	0.00151	CcSEcCtD
Desloratadine—Infestation—Capecitabine—kidney cancer	0.000271	0.00151	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000271	0.00151	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.00027	0.00151	CcSEcCtD
Desloratadine—Asthenia—Vinblastine—kidney cancer	0.00027	0.00151	CcSEcCtD
Desloratadine—Fatigue—Sunitinib—kidney cancer	0.00027	0.00151	CcSEcCtD
Desloratadine—Asthenia—Everolimus—kidney cancer	0.000269	0.0015	CcSEcCtD
Desloratadine—Cough—Gemcitabine—kidney cancer	0.000269	0.0015	CcSEcCtD
Desloratadine—Gastrointestinal pain—Sorafenib—kidney cancer	0.000266	0.00149	CcSEcCtD
Desloratadine—Pruritus—Everolimus—kidney cancer	0.000266	0.00148	CcSEcCtD
Desloratadine—Anaphylactic shock—Vincristine—kidney cancer	0.000265	0.00148	CcSEcCtD
Desloratadine—Oedema—Vincristine—kidney cancer	0.000265	0.00148	CcSEcCtD
Desloratadine—Infection—Vincristine—kidney cancer	0.000263	0.00147	CcSEcCtD
Desloratadine—Urinary tract infection—Capecitabine—kidney cancer	0.000263	0.00147	CcSEcCtD
Desloratadine—Myalgia—Gemcitabine—kidney cancer	0.000262	0.00146	CcSEcCtD
Desloratadine—Nervous system disorder—Vincristine—kidney cancer	0.00026	0.00145	CcSEcCtD
Desloratadine—Asthenia—Erlotinib—kidney cancer	0.00026	0.00145	CcSEcCtD
Desloratadine—Mental disorder—Paclitaxel—kidney cancer	0.00026	0.00145	CcSEcCtD
Desloratadine—Urticaria—Sorafenib—kidney cancer	0.000259	0.00144	CcSEcCtD
Desloratadine—Erythema—Paclitaxel—kidney cancer	0.000258	0.00144	CcSEcCtD
Desloratadine—Decreased appetite—Dactinomycin—kidney cancer	0.000258	0.00144	CcSEcCtD
Desloratadine—Diarrhoea—Vinblastine—kidney cancer	0.000258	0.00144	CcSEcCtD
Desloratadine—Abdominal pain—Sorafenib—kidney cancer	0.000258	0.00144	CcSEcCtD
Desloratadine—Body temperature increased—Sorafenib—kidney cancer	0.000258	0.00144	CcSEcCtD
Desloratadine—Diarrhoea—Everolimus—kidney cancer	0.000257	0.00143	CcSEcCtD
Desloratadine—Gastrointestinal pain—Sunitinib—kidney cancer	0.000256	0.00143	CcSEcCtD
Desloratadine—Hepatobiliary disease—Capecitabine—kidney cancer	0.000256	0.00143	CcSEcCtD
Desloratadine—Pruritus—Erlotinib—kidney cancer	0.000256	0.00143	CcSEcCtD
Desloratadine—Fatigue—Dactinomycin—kidney cancer	0.000256	0.00143	CcSEcCtD
Desloratadine—Epistaxis—Capecitabine—kidney cancer	0.000256	0.00142	CcSEcCtD
Desloratadine—Anorexia—Vincristine—kidney cancer	0.000253	0.00141	CcSEcCtD
Desloratadine—Anaphylactic shock—Gemcitabine—kidney cancer	0.000252	0.0014	CcSEcCtD
Desloratadine—Oedema—Gemcitabine—kidney cancer	0.000252	0.0014	CcSEcCtD
Desloratadine—Infection—Gemcitabine—kidney cancer	0.00025	0.00139	CcSEcCtD
Desloratadine—Dizziness—Vinblastine—kidney cancer	0.000249	0.00139	CcSEcCtD
Desloratadine—Dizziness—Everolimus—kidney cancer	0.000248	0.00138	CcSEcCtD
Desloratadine—Abdominal pain—Sunitinib—kidney cancer	0.000248	0.00138	CcSEcCtD
Desloratadine—Body temperature increased—Sunitinib—kidney cancer	0.000248	0.00138	CcSEcCtD
Desloratadine—Diarrhoea—Erlotinib—kidney cancer	0.000248	0.00138	CcSEcCtD
Desloratadine—Nervous system disorder—Gemcitabine—kidney cancer	0.000247	0.00138	CcSEcCtD
Desloratadine—Hepatitis—Capecitabine—kidney cancer	0.000243	0.00136	CcSEcCtD
Desloratadine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000243	0.00135	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000242	0.00135	CcSEcCtD
Desloratadine—Pharyngitis—Capecitabine—kidney cancer	0.000241	0.00135	CcSEcCtD
Desloratadine—Increased appetite—Doxorubicin—kidney cancer	0.000241	0.00134	CcSEcCtD
Desloratadine—Hypersensitivity—Sorafenib—kidney cancer	0.00024	0.00134	CcSEcCtD
Desloratadine—Insomnia—Vincristine—kidney cancer	0.00024	0.00134	CcSEcCtD
Desloratadine—Anorexia—Gemcitabine—kidney cancer	0.00024	0.00134	CcSEcCtD
Desloratadine—Vomiting—Vinblastine—kidney cancer	0.00024	0.00134	CcSEcCtD
Desloratadine—Dizziness—Erlotinib—kidney cancer	0.000239	0.00133	CcSEcCtD
Desloratadine—Connective tissue disorder—Capecitabine—kidney cancer	0.000239	0.00133	CcSEcCtD
Desloratadine—Vomiting—Everolimus—kidney cancer	0.000239	0.00133	CcSEcCtD
Desloratadine—Agitation—Paclitaxel—kidney cancer	0.000237	0.00132	CcSEcCtD
Desloratadine—Rash—Everolimus—kidney cancer	0.000237	0.00132	CcSEcCtD
Desloratadine—Dermatitis—Everolimus—kidney cancer	0.000236	0.00132	CcSEcCtD
Desloratadine—Headache—Vinblastine—kidney cancer	0.000236	0.00132	CcSEcCtD
Desloratadine—Angioedema—Paclitaxel—kidney cancer	0.000236	0.00131	CcSEcCtD
Desloratadine—Headache—Everolimus—kidney cancer	0.000235	0.00131	CcSEcCtD
Desloratadine—Abdominal pain—Dactinomycin—kidney cancer	0.000235	0.00131	CcSEcCtD
Desloratadine—Body temperature increased—Dactinomycin—kidney cancer	0.000235	0.00131	CcSEcCtD
Desloratadine—Asthenia—Sorafenib—kidney cancer	0.000234	0.0013	CcSEcCtD
Desloratadine—Hypersensitivity—Sunitinib—kidney cancer	0.000231	0.00129	CcSEcCtD
Desloratadine—Decreased appetite—Vincristine—kidney cancer	0.00023	0.00128	CcSEcCtD
Desloratadine—Pruritus—Sorafenib—kidney cancer	0.00023	0.00128	CcSEcCtD
Desloratadine—Vomiting—Erlotinib—kidney cancer	0.00023	0.00128	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000229	0.00128	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Vincristine—kidney cancer	0.000229	0.00128	CcSEcCtD
Desloratadine—Fatigue—Vincristine—kidney cancer	0.000229	0.00127	CcSEcCtD
Desloratadine—Rash—Erlotinib—kidney cancer	0.000228	0.00127	CcSEcCtD
Desloratadine—Dermatitis—Erlotinib—kidney cancer	0.000228	0.00127	CcSEcCtD
Desloratadine—Palpitations—Paclitaxel—kidney cancer	0.000228	0.00127	CcSEcCtD
Desloratadine—Insomnia—Gemcitabine—kidney cancer	0.000227	0.00127	CcSEcCtD
Desloratadine—Headache—Erlotinib—kidney cancer	0.000227	0.00126	CcSEcCtD
Desloratadine—Cardiac disorder—Capecitabine—kidney cancer	0.000226	0.00126	CcSEcCtD
Desloratadine—Cough—Paclitaxel—kidney cancer	0.000225	0.00126	CcSEcCtD
Desloratadine—Asthenia—Sunitinib—kidney cancer	0.000225	0.00125	CcSEcCtD
Desloratadine—Dyspnoea—Gemcitabine—kidney cancer	0.000224	0.00125	CcSEcCtD
Desloratadine—Nausea—Vinblastine—kidney cancer	0.000224	0.00125	CcSEcCtD
Desloratadine—Somnolence—Gemcitabine—kidney cancer	0.000224	0.00125	CcSEcCtD
Desloratadine—Convulsion—Paclitaxel—kidney cancer	0.000224	0.00125	CcSEcCtD
Desloratadine—Affect lability—Doxorubicin—kidney cancer	0.000223	0.00124	CcSEcCtD
Desloratadine—Nausea—Everolimus—kidney cancer	0.000223	0.00124	CcSEcCtD
Desloratadine—Diarrhoea—Sorafenib—kidney cancer	0.000223	0.00124	CcSEcCtD
Desloratadine—Pruritus—Sunitinib—kidney cancer	0.000222	0.00124	CcSEcCtD
Desloratadine—Myalgia—Paclitaxel—kidney cancer	0.00022	0.00122	CcSEcCtD
Desloratadine—Decreased appetite—Gemcitabine—kidney cancer	0.000219	0.00122	CcSEcCtD
Desloratadine—Hypersensitivity—Dactinomycin—kidney cancer	0.000219	0.00122	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000217	0.00121	CcSEcCtD
Desloratadine—Fatigue—Gemcitabine—kidney cancer	0.000217	0.00121	CcSEcCtD
Desloratadine—Gastrointestinal pain—Vincristine—kidney cancer	0.000217	0.00121	CcSEcCtD
Desloratadine—Dizziness—Sorafenib—kidney cancer	0.000215	0.0012	CcSEcCtD
Desloratadine—Nausea—Erlotinib—kidney cancer	0.000215	0.0012	CcSEcCtD
Desloratadine—Dry mouth—Paclitaxel—kidney cancer	0.000215	0.0012	CcSEcCtD
Desloratadine—Mood swings—Doxorubicin—kidney cancer	0.000215	0.0012	CcSEcCtD
Desloratadine—Diarrhoea—Sunitinib—kidney cancer	0.000214	0.0012	CcSEcCtD
Desloratadine—Mental disorder—Capecitabine—kidney cancer	0.000213	0.00119	CcSEcCtD
Desloratadine—Asthenia—Dactinomycin—kidney cancer	0.000213	0.00119	CcSEcCtD
Desloratadine—Erythema—Capecitabine—kidney cancer	0.000212	0.00118	CcSEcCtD
Desloratadine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000211	0.00117	CcSEcCtD
Desloratadine—Oedema—Paclitaxel—kidney cancer	0.000211	0.00117	CcSEcCtD
Desloratadine—Body temperature increased—Vincristine—kidney cancer	0.00021	0.00117	CcSEcCtD
Desloratadine—Abdominal pain—Vincristine—kidney cancer	0.00021	0.00117	CcSEcCtD
Desloratadine—Infection—Paclitaxel—kidney cancer	0.000209	0.00117	CcSEcCtD
Desloratadine—Dizziness—Sunitinib—kidney cancer	0.000207	0.00116	CcSEcCtD
Desloratadine—Vomiting—Sorafenib—kidney cancer	0.000207	0.00115	CcSEcCtD
Desloratadine—Nervous system disorder—Paclitaxel—kidney cancer	0.000207	0.00115	CcSEcCtD
Desloratadine—Tachycardia—Paclitaxel—kidney cancer	0.000206	0.00115	CcSEcCtD
Desloratadine—Rash—Sorafenib—kidney cancer	0.000205	0.00115	CcSEcCtD
Desloratadine—Dermatitis—Sorafenib—kidney cancer	0.000205	0.00114	CcSEcCtD
Desloratadine—Breast disorder—Doxorubicin—kidney cancer	0.000205	0.00114	CcSEcCtD
Desloratadine—Headache—Sorafenib—kidney cancer	0.000204	0.00114	CcSEcCtD
Desloratadine—Diarrhoea—Dactinomycin—kidney cancer	0.000203	0.00113	CcSEcCtD
Desloratadine—Nasopharyngitis—Doxorubicin—kidney cancer	0.000203	0.00113	CcSEcCtD
Desloratadine—Anorexia—Paclitaxel—kidney cancer	0.000201	0.00112	CcSEcCtD
Desloratadine—Vomiting—Sunitinib—kidney cancer	0.000199	0.00111	CcSEcCtD
Desloratadine—Body temperature increased—Gemcitabine—kidney cancer	0.000199	0.00111	CcSEcCtD
Desloratadine—Rash—Sunitinib—kidney cancer	0.000198	0.0011	CcSEcCtD
Desloratadine—Dermatitis—Sunitinib—kidney cancer	0.000197	0.0011	CcSEcCtD
Desloratadine—Headache—Sunitinib—kidney cancer	0.000196	0.00109	CcSEcCtD
Desloratadine—Hypersensitivity—Vincristine—kidney cancer	0.000195	0.00109	CcSEcCtD
Desloratadine—Nausea—Sorafenib—kidney cancer	0.000193	0.00108	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000192	0.00107	CcSEcCtD
Desloratadine—Insomnia—Paclitaxel—kidney cancer	0.00019	0.00106	CcSEcCtD
Desloratadine—Asthenia—Vincristine—kidney cancer	0.00019	0.00106	CcSEcCtD
Desloratadine—Vomiting—Dactinomycin—kidney cancer	0.000189	0.00105	CcSEcCtD
Desloratadine—Bronchitis—Doxorubicin—kidney cancer	0.000188	0.00105	CcSEcCtD
Desloratadine—Dyspnoea—Paclitaxel—kidney cancer	0.000188	0.00105	CcSEcCtD
Desloratadine—Somnolence—Paclitaxel—kidney cancer	0.000187	0.00104	CcSEcCtD
Desloratadine—Palpitations—Capecitabine—kidney cancer	0.000187	0.00104	CcSEcCtD
Desloratadine—Rash—Dactinomycin—kidney cancer	0.000187	0.00104	CcSEcCtD
Desloratadine—Nausea—Sunitinib—kidney cancer	0.000186	0.00104	CcSEcCtD
Desloratadine—Dyspepsia—Paclitaxel—kidney cancer	0.000185	0.00103	CcSEcCtD
Desloratadine—Cough—Capecitabine—kidney cancer	0.000185	0.00103	CcSEcCtD
Desloratadine—Decreased appetite—Paclitaxel—kidney cancer	0.000183	0.00102	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000182	0.00101	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000182	0.00101	CcSEcCtD
Desloratadine—Fatigue—Paclitaxel—kidney cancer	0.000182	0.00101	CcSEcCtD
Desloratadine—Diarrhoea—Vincristine—kidney cancer	0.000181	0.00101	CcSEcCtD
Desloratadine—Asthenia—Gemcitabine—kidney cancer	0.00018	0.00101	CcSEcCtD
Desloratadine—Myalgia—Capecitabine—kidney cancer	0.00018	0.001	CcSEcCtD
Desloratadine—Pruritus—Gemcitabine—kidney cancer	0.000178	0.000992	CcSEcCtD
Desloratadine—Dry mouth—Capecitabine—kidney cancer	0.000176	0.000983	CcSEcCtD
Desloratadine—Nausea—Dactinomycin—kidney cancer	0.000176	0.000983	CcSEcCtD
Desloratadine—Dizziness—Vincristine—kidney cancer	0.000175	0.000977	CcSEcCtD
Desloratadine—Infestation NOS—Doxorubicin—kidney cancer	0.000175	0.000974	CcSEcCtD
Desloratadine—Infestation—Doxorubicin—kidney cancer	0.000175	0.000974	CcSEcCtD
Desloratadine—Oedema—Capecitabine—kidney cancer	0.000173	0.000963	CcSEcCtD
Desloratadine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000172	0.00096	CcSEcCtD
Desloratadine—Diarrhoea—Gemcitabine—kidney cancer	0.000172	0.000959	CcSEcCtD
Desloratadine—Infection—Capecitabine—kidney cancer	0.000172	0.000957	CcSEcCtD
Desloratadine—Urinary tract infection—Doxorubicin—kidney cancer	0.00017	0.000946	CcSEcCtD
Desloratadine—Nervous system disorder—Capecitabine—kidney cancer	0.000169	0.000945	CcSEcCtD
Desloratadine—Tachycardia—Capecitabine—kidney cancer	0.000169	0.00094	CcSEcCtD
Desloratadine—Vomiting—Vincristine—kidney cancer	0.000169	0.00094	CcSEcCtD
Desloratadine—Urticaria—Paclitaxel—kidney cancer	0.000167	0.000933	CcSEcCtD
Desloratadine—Rash—Vincristine—kidney cancer	0.000167	0.000932	CcSEcCtD
Desloratadine—Dermatitis—Vincristine—kidney cancer	0.000167	0.000931	CcSEcCtD
Desloratadine—Body temperature increased—Paclitaxel—kidney cancer	0.000166	0.000928	CcSEcCtD
Desloratadine—Abdominal pain—Paclitaxel—kidney cancer	0.000166	0.000928	CcSEcCtD
Desloratadine—Headache—Vincristine—kidney cancer	0.000166	0.000926	CcSEcCtD
Desloratadine—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000165	0.000921	CcSEcCtD
Desloratadine—Epistaxis—Doxorubicin—kidney cancer	0.000165	0.000918	CcSEcCtD
Desloratadine—Anorexia—Capecitabine—kidney cancer	0.000165	0.000918	CcSEcCtD
Desloratadine—Vomiting—Gemcitabine—kidney cancer	0.00016	0.000892	CcSEcCtD
Desloratadine—Rash—Gemcitabine—kidney cancer	0.000159	0.000884	CcSEcCtD
Desloratadine—Dermatitis—Gemcitabine—kidney cancer	0.000158	0.000883	CcSEcCtD
Desloratadine—Headache—Gemcitabine—kidney cancer	0.000158	0.000878	CcSEcCtD
Desloratadine—Nausea—Vincristine—kidney cancer	0.000157	0.000878	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000157	0.000878	CcSEcCtD
Desloratadine—Hepatitis—Doxorubicin—kidney cancer	0.000157	0.000874	CcSEcCtD
Desloratadine—Insomnia—Capecitabine—kidney cancer	0.000156	0.000871	CcSEcCtD
Desloratadine—Pharyngitis—Doxorubicin—kidney cancer	0.000156	0.000868	CcSEcCtD
Desloratadine—Hypersensitivity—Paclitaxel—kidney cancer	0.000155	0.000865	CcSEcCtD
Desloratadine—Connective tissue disorder—Doxorubicin—kidney cancer	0.000154	0.000859	CcSEcCtD
Desloratadine—Dyspnoea—Capecitabine—kidney cancer	0.000154	0.000859	CcSEcCtD
Desloratadine—Dyspepsia—Capecitabine—kidney cancer	0.000152	0.000848	CcSEcCtD
Desloratadine—Asthenia—Paclitaxel—kidney cancer	0.000151	0.000842	CcSEcCtD
Desloratadine—Decreased appetite—Capecitabine—kidney cancer	0.00015	0.000837	CcSEcCtD
Desloratadine—Nausea—Gemcitabine—kidney cancer	0.000149	0.000833	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000149	0.000832	CcSEcCtD
Desloratadine—Fatigue—Capecitabine—kidney cancer	0.000149	0.000831	CcSEcCtD
Desloratadine—Pruritus—Paclitaxel—kidney cancer	0.000149	0.000831	CcSEcCtD
Desloratadine—Cardiac disorder—Doxorubicin—kidney cancer	0.000146	0.000811	CcSEcCtD
Desloratadine—Diarrhoea—Paclitaxel—kidney cancer	0.000144	0.000803	CcSEcCtD
Desloratadine—Gastrointestinal pain—Capecitabine—kidney cancer	0.000141	0.000788	CcSEcCtD
Desloratadine—Dizziness—Paclitaxel—kidney cancer	0.000139	0.000776	CcSEcCtD
Desloratadine—Mental disorder—Doxorubicin—kidney cancer	0.000137	0.000766	CcSEcCtD
Desloratadine—Urticaria—Capecitabine—kidney cancer	0.000137	0.000765	CcSEcCtD
Desloratadine—Abdominal pain—Capecitabine—kidney cancer	0.000137	0.000762	CcSEcCtD
Desloratadine—Body temperature increased—Capecitabine—kidney cancer	0.000137	0.000762	CcSEcCtD
Desloratadine—Erythema—Doxorubicin—kidney cancer	0.000136	0.000761	CcSEcCtD
Desloratadine—Vomiting—Paclitaxel—kidney cancer	0.000134	0.000746	CcSEcCtD
Desloratadine—Rash—Paclitaxel—kidney cancer	0.000133	0.00074	CcSEcCtD
Desloratadine—Dermatitis—Paclitaxel—kidney cancer	0.000133	0.00074	CcSEcCtD
Desloratadine—Headache—Paclitaxel—kidney cancer	0.000132	0.000735	CcSEcCtD
Desloratadine—Hypersensitivity—Capecitabine—kidney cancer	0.000127	0.00071	CcSEcCtD
Desloratadine—Agitation—Doxorubicin—kidney cancer	0.000125	0.000699	CcSEcCtD
Desloratadine—Nausea—Paclitaxel—kidney cancer	0.000125	0.000697	CcSEcCtD
Desloratadine—Asthenia—Capecitabine—kidney cancer	0.000124	0.000691	CcSEcCtD
Desloratadine—Pruritus—Capecitabine—kidney cancer	0.000122	0.000682	CcSEcCtD
Desloratadine—Palpitations—Doxorubicin—kidney cancer	0.000121	0.000672	CcSEcCtD
Desloratadine—Cough—Doxorubicin—kidney cancer	0.000119	0.000664	CcSEcCtD
Desloratadine—Convulsion—Doxorubicin—kidney cancer	0.000118	0.000659	CcSEcCtD
Desloratadine—Diarrhoea—Capecitabine—kidney cancer	0.000118	0.000659	CcSEcCtD
Desloratadine—Myalgia—Doxorubicin—kidney cancer	0.000116	0.000648	CcSEcCtD
Desloratadine—Dizziness—Capecitabine—kidney cancer	0.000114	0.000637	CcSEcCtD
Desloratadine—Dry mouth—Doxorubicin—kidney cancer	0.000114	0.000634	CcSEcCtD
Desloratadine—Oedema—Doxorubicin—kidney cancer	0.000111	0.000621	CcSEcCtD
Desloratadine—Anaphylactic shock—Doxorubicin—kidney cancer	0.000111	0.000621	CcSEcCtD
Desloratadine—Infection—Doxorubicin—kidney cancer	0.000111	0.000617	CcSEcCtD
Desloratadine—Vomiting—Capecitabine—kidney cancer	0.00011	0.000613	CcSEcCtD
Desloratadine—Nervous system disorder—Doxorubicin—kidney cancer	0.000109	0.000609	CcSEcCtD
Desloratadine—Rash—Capecitabine—kidney cancer	0.000109	0.000607	CcSEcCtD
Desloratadine—Dermatitis—Capecitabine—kidney cancer	0.000109	0.000607	CcSEcCtD
Desloratadine—Tachycardia—Doxorubicin—kidney cancer	0.000109	0.000606	CcSEcCtD
Desloratadine—Headache—Capecitabine—kidney cancer	0.000108	0.000604	CcSEcCtD
Desloratadine—Anorexia—Doxorubicin—kidney cancer	0.000106	0.000592	CcSEcCtD
Desloratadine—Nausea—Capecitabine—kidney cancer	0.000103	0.000572	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000101	0.000566	CcSEcCtD
Desloratadine—Insomnia—Doxorubicin—kidney cancer	0.000101	0.000562	CcSEcCtD
Desloratadine—Dyspnoea—Doxorubicin—kidney cancer	9.93e-05	0.000554	CcSEcCtD
Desloratadine—Somnolence—Doxorubicin—kidney cancer	9.9e-05	0.000552	CcSEcCtD
Desloratadine—Dyspepsia—Doxorubicin—kidney cancer	9.81e-05	0.000547	CcSEcCtD
Desloratadine—Decreased appetite—Doxorubicin—kidney cancer	9.68e-05	0.00054	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Doxorubicin—kidney cancer	9.62e-05	0.000536	CcSEcCtD
Desloratadine—Fatigue—Doxorubicin—kidney cancer	9.6e-05	0.000535	CcSEcCtD
Desloratadine—CYP1A2—renal system—kidney cancer	9.38e-05	0.0481	CbGeAlD
Desloratadine—Gastrointestinal pain—Doxorubicin—kidney cancer	9.11e-05	0.000508	CcSEcCtD
Desloratadine—Urticaria—Doxorubicin—kidney cancer	8.85e-05	0.000493	CcSEcCtD
Desloratadine—Abdominal pain—Doxorubicin—kidney cancer	8.81e-05	0.000491	CcSEcCtD
Desloratadine—Body temperature increased—Doxorubicin—kidney cancer	8.81e-05	0.000491	CcSEcCtD
Desloratadine—Hypersensitivity—Doxorubicin—kidney cancer	8.21e-05	0.000458	CcSEcCtD
Desloratadine—Asthenia—Doxorubicin—kidney cancer	7.99e-05	0.000446	CcSEcCtD
Desloratadine—Pruritus—Doxorubicin—kidney cancer	7.88e-05	0.000439	CcSEcCtD
Desloratadine—Diarrhoea—Doxorubicin—kidney cancer	7.62e-05	0.000425	CcSEcCtD
Desloratadine—Dizziness—Doxorubicin—kidney cancer	7.37e-05	0.000411	CcSEcCtD
Desloratadine—Vomiting—Doxorubicin—kidney cancer	7.08e-05	0.000395	CcSEcCtD
Desloratadine—Rash—Doxorubicin—kidney cancer	7.02e-05	0.000392	CcSEcCtD
Desloratadine—Dermatitis—Doxorubicin—kidney cancer	7.02e-05	0.000391	CcSEcCtD
Desloratadine—Headache—Doxorubicin—kidney cancer	6.98e-05	0.000389	CcSEcCtD
Desloratadine—CYP2D6—renal system—kidney cancer	6.68e-05	0.0342	CbGeAlD
Desloratadine—Nausea—Doxorubicin—kidney cancer	6.62e-05	0.000369	CcSEcCtD
Desloratadine—CYP2D6—kidney—kidney cancer	6.46e-05	0.0331	CbGeAlD
Desloratadine—ABCB1—nephron tubule—kidney cancer	5.28e-05	0.0271	CbGeAlD
Desloratadine—ABCB1—renal system—kidney cancer	4.8e-05	0.0246	CbGeAlD
Desloratadine—ABCB1—kidney—kidney cancer	4.64e-05	0.0238	CbGeAlD
Desloratadine—ABCB1—cortex of kidney—kidney cancer	4.52e-05	0.0232	CbGeAlD
Desloratadine—ABCB1—gonad—kidney cancer	4.31e-05	0.0221	CbGeAlD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	8.85e-06	0.000864	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	8.76e-06	0.000855	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—ANXA1—kidney cancer	8.7e-06	0.000849	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—FH—kidney cancer	8.65e-06	0.000844	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—APRT—kidney cancer	8.65e-06	0.000844	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PPAT—kidney cancer	8.56e-06	0.000835	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GLIPR1—kidney cancer	8.56e-06	0.000835	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PPAT—kidney cancer	8.48e-06	0.000828	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GLIPR1—kidney cancer	8.48e-06	0.000828	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	8.45e-06	0.000825	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—APRT—kidney cancer	8.44e-06	0.000824	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—FH—kidney cancer	8.44e-06	0.000824	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	8.42e-06	0.000822	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	8.37e-06	0.000817	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CCBL1—kidney cancer	8.36e-06	0.000816	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	8.33e-06	0.000813	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	8.33e-06	0.000813	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—POMC—kidney cancer	8.31e-06	0.000811	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	8.29e-06	0.000809	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	8.14e-06	0.000795	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GPC3—kidney cancer	8.13e-06	0.000794	CbGpPWpGaD
Desloratadine—HRH1—G alpha (q) signalling events—PIK3CA—kidney cancer	8.08e-06	0.000789	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—APRT—kidney cancer	7.95e-06	0.000776	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—FH—kidney cancer	7.95e-06	0.000776	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GPC3—kidney cancer	7.94e-06	0.000775	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CA2—kidney cancer	7.91e-06	0.000772	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—FH—kidney cancer	7.89e-06	0.00077	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—APRT—kidney cancer	7.89e-06	0.00077	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	7.87e-06	0.000768	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	7.75e-06	0.000756	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CA2—kidney cancer	7.72e-06	0.000754	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	7.71e-06	0.000753	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ALAD—kidney cancer	7.71e-06	0.000752	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	7.71e-06	0.000752	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	7.56e-06	0.000738	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ST3GAL2—kidney cancer	7.52e-06	0.000734	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ALAD—kidney cancer	7.52e-06	0.000734	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	7.48e-06	0.00073	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GPC3—kidney cancer	7.48e-06	0.00073	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GPC3—kidney cancer	7.41e-06	0.000724	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	7.36e-06	0.000718	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ALDH1A1—kidney cancer	7.35e-06	0.000718	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ST3GAL2—kidney cancer	7.34e-06	0.000717	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	7.34e-06	0.000717	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	7.29e-06	0.000711	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CA2—kidney cancer	7.27e-06	0.00071	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PPAT—kidney cancer	7.25e-06	0.000707	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GLIPR1—kidney cancer	7.25e-06	0.000707	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	7.23e-06	0.000706	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CASP2—kidney cancer	7.21e-06	0.000704	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—AKAP13—kidney cancer	7.21e-06	0.000704	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CA2—kidney cancer	7.21e-06	0.000704	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ALDH1A1—kidney cancer	7.18e-06	0.000701	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	7.16e-06	0.000699	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	7.1e-06	0.000693	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ALAD—kidney cancer	7.09e-06	0.000692	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	7.08e-06	0.000691	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PGK1—kidney cancer	7.05e-06	0.000688	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—SLC5A3—kidney cancer	7.05e-06	0.000688	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ALAD—kidney cancer	7.03e-06	0.000686	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ST3GAL2—kidney cancer	6.92e-06	0.000675	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—LDHB—kidney cancer	6.91e-06	0.000675	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—SLC5A3—kidney cancer	6.88e-06	0.000672	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PGK1—kidney cancer	6.88e-06	0.000672	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ST3GAL2—kidney cancer	6.86e-06	0.00067	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ALDH1A1—kidney cancer	6.76e-06	0.00066	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—LDHB—kidney cancer	6.75e-06	0.000659	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—APRT—kidney cancer	6.74e-06	0.000658	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—FH—kidney cancer	6.74e-06	0.000658	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ALDH1A1—kidney cancer	6.7e-06	0.000654	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—GRB7—kidney cancer	6.6e-06	0.000644	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	6.59e-06	0.000643	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PGK1—kidney cancer	6.48e-06	0.000633	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—SLC5A3—kidney cancer	6.48e-06	0.000633	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—SLC5A3—kidney cancer	6.43e-06	0.000627	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PGK1—kidney cancer	6.43e-06	0.000627	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	6.41e-06	0.000626	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—LDHB—kidney cancer	6.36e-06	0.000621	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GPC3—kidney cancer	6.34e-06	0.000618	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—LDHB—kidney cancer	6.3e-06	0.000615	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CA2—kidney cancer	6.16e-06	0.000602	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ITPR2—kidney cancer	6.13e-06	0.000599	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	6.07e-06	0.000592	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ALAD—kidney cancer	6.01e-06	0.000586	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CA9—kidney cancer	5.99e-06	0.000585	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	5.9e-06	0.000576	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ST3GAL2—kidney cancer	5.86e-06	0.000572	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	5.86e-06	0.000572	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CA9—kidney cancer	5.85e-06	0.000571	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	5.77e-06	0.000564	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ALDH1A1—kidney cancer	5.73e-06	0.000559	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CTNNA1—kidney cancer	5.56e-06	0.000543	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HSPB1—kidney cancer	5.53e-06	0.00054	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—EIF4EBP1—kidney cancer	5.53e-06	0.00054	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CA9—kidney cancer	5.51e-06	0.000538	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—SLC5A3—kidney cancer	5.49e-06	0.000536	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PGK1—kidney cancer	5.49e-06	0.000536	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CA9—kidney cancer	5.47e-06	0.000533	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	5.45e-06	0.000532	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—LDHB—kidney cancer	5.39e-06	0.000526	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	5.34e-06	0.000521	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TSC1—kidney cancer	5.14e-06	0.000502	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PSMD7—kidney cancer	5.14e-06	0.000502	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ANXA1—kidney cancer	5.14e-06	0.000502	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CRABP1—kidney cancer	5.1e-06	0.000497	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	5.01e-06	0.000489	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FLT1—kidney cancer	4.98e-06	0.000486	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CRABP1—kidney cancer	4.97e-06	0.000486	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	4.85e-06	0.000473	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ITPR2—kidney cancer	4.74e-06	0.000463	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—POMC—kidney cancer	4.69e-06	0.000458	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CRABP1—kidney cancer	4.69e-06	0.000458	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CA9—kidney cancer	4.67e-06	0.000456	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CRABP1—kidney cancer	4.65e-06	0.000454	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ITPR2—kidney cancer	4.62e-06	0.000451	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PAK1—kidney cancer	4.61e-06	0.00045	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—JUNB—kidney cancer	4.61e-06	0.00045	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.56e-06	0.000446	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.37e-06	0.000426	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ITPR2—kidney cancer	4.36e-06	0.000425	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ACHE—kidney cancer	4.32e-06	0.000422	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTT1—kidney cancer	4.32e-06	0.000422	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ITPR2—kidney cancer	4.32e-06	0.000422	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—POMC—kidney cancer	4.26e-06	0.000416	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTT1—kidney cancer	4.22e-06	0.000412	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ACHE—kidney cancer	4.22e-06	0.000412	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—SCARB1—kidney cancer	4.09e-06	0.000399	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PTGS1—kidney cancer	4.05e-06	0.000395	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—SCARB1—kidney cancer	3.99e-06	0.00039	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.98e-06	0.000389	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTT1—kidney cancer	3.97e-06	0.000388	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ACHE—kidney cancer	3.97e-06	0.000388	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CRABP1—kidney cancer	3.97e-06	0.000388	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PSMD7—kidney cancer	3.97e-06	0.000388	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PTGS1—kidney cancer	3.95e-06	0.000386	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ACHE—kidney cancer	3.94e-06	0.000385	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTT1—kidney cancer	3.94e-06	0.000385	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PSMD7—kidney cancer	3.88e-06	0.000378	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IGF2—kidney cancer	3.77e-06	0.000368	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—BCHE—kidney cancer	3.76e-06	0.000367	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—SCARB1—kidney cancer	3.76e-06	0.000367	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CDKN2B—kidney cancer	3.76e-06	0.000367	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—SCARB1—kidney cancer	3.73e-06	0.000364	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PTGS1—kidney cancer	3.72e-06	0.000364	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—SLC5A5—kidney cancer	3.72e-06	0.000363	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ITPR2—kidney cancer	3.69e-06	0.00036	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PTGS1—kidney cancer	3.69e-06	0.00036	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—BCHE—kidney cancer	3.67e-06	0.000359	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PSMD7—kidney cancer	3.65e-06	0.000356	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IGF1R—kidney cancer	3.65e-06	0.000356	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—SLC5A5—kidney cancer	3.63e-06	0.000354	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PSMD7—kidney cancer	3.62e-06	0.000353	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—SLC2A1—kidney cancer	3.59e-06	0.000351	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—RAF1—kidney cancer	3.51e-06	0.000343	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—SLC2A1—kidney cancer	3.5e-06	0.000342	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.48e-06	0.00034	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—IL2—kidney cancer	3.47e-06	0.000339	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—BCHE—kidney cancer	3.46e-06	0.000338	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—BCHE—kidney cancer	3.43e-06	0.000335	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—SLC5A5—kidney cancer	3.42e-06	0.000334	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.4e-06	0.000332	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—SLC5A5—kidney cancer	3.39e-06	0.000331	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ACHE—kidney cancer	3.37e-06	0.000329	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTT1—kidney cancer	3.37e-06	0.000329	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.34e-06	0.000326	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—SLC2A1—kidney cancer	3.3e-06	0.000322	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—SLC2A1—kidney cancer	3.27e-06	0.00032	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—SCARB1—kidney cancer	3.19e-06	0.000311	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.18e-06	0.00031	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PTGS1—kidney cancer	3.15e-06	0.000308	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL2—kidney cancer	3.15e-06	0.000308	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PSMD7—kidney cancer	3.09e-06	0.000302	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.04e-06	0.000297	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HIF1A—kidney cancer	3e-06	0.000293	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TSC2—kidney cancer	3e-06	0.000292	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTP1—kidney cancer	2.99e-06	0.000292	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—BCHE—kidney cancer	2.93e-06	0.000286	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTP1—kidney cancer	2.92e-06	0.000285	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—SLC5A5—kidney cancer	2.9e-06	0.000283	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KDR—kidney cancer	2.87e-06	0.00028	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ABCB1—kidney cancer	2.84e-06	0.000277	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—SLC2A1—kidney cancer	2.8e-06	0.000273	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.77e-06	0.00027	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTP1—kidney cancer	2.75e-06	0.000269	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTM1—kidney cancer	2.75e-06	0.000269	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTP1—kidney cancer	2.73e-06	0.000267	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.71e-06	0.000265	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTM1—kidney cancer	2.69e-06	0.000262	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—APC—kidney cancer	2.65e-06	0.000258	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KIT—kidney cancer	2.65e-06	0.000258	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP1A1—kidney cancer	2.61e-06	0.000255	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ABCB1—kidney cancer	2.61e-06	0.000255	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ABCB1—kidney cancer	2.59e-06	0.000252	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP1A1—kidney cancer	2.55e-06	0.000249	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—MAPK3—kidney cancer	2.53e-06	0.000247	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTM1—kidney cancer	2.53e-06	0.000247	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—POMC—kidney cancer	2.52e-06	0.000246	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTM1—kidney cancer	2.51e-06	0.000245	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—BRAF—kidney cancer	2.49e-06	0.000243	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—MAPK1—kidney cancer	2.41e-06	0.000235	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP1A1—kidney cancer	2.4e-06	0.000234	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP1A1—kidney cancer	2.38e-06	0.000232	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.37e-06	0.000231	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTP1—kidney cancer	2.33e-06	0.000228	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PIK3CA—kidney cancer	2.3e-06	0.000225	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—KRAS—kidney cancer	2.28e-06	0.000222	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ABCB1—kidney cancer	2.21e-06	0.000216	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTM1—kidney cancer	2.14e-06	0.000209	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.14e-06	0.000209	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CA—kidney cancer	2.09e-06	0.000204	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—RAF1—kidney cancer	2.08e-06	0.000203	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—RELA—kidney cancer	2.07e-06	0.000202	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ERBB2—kidney cancer	2.05e-06	0.000201	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP1A1—kidney cancer	2.03e-06	0.000198	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MTOR—kidney cancer	2.03e-06	0.000198	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.95e-06	0.000191	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—POMC—kidney cancer	1.95e-06	0.00019	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CDKN1B—kidney cancer	1.9e-06	0.000186	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—POMC—kidney cancer	1.9e-06	0.000185	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL2—kidney cancer	1.86e-06	0.000182	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CCND1—kidney cancer	1.81e-06	0.000177	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—JUN—kidney cancer	1.81e-06	0.000177	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CTNNB1—kidney cancer	1.8e-06	0.000175	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—POMC—kidney cancer	1.79e-06	0.000175	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—POMC—kidney cancer	1.77e-06	0.000173	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PTEN—kidney cancer	1.75e-06	0.000171	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.67e-06	0.000163	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—VEGFA—kidney cancer	1.58e-06	0.000154	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PTGS2—kidney cancer	1.55e-06	0.000151	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—POMC—kidney cancer	1.52e-06	0.000148	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PTGS2—kidney cancer	1.51e-06	0.000148	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MAPK3—kidney cancer	1.5e-06	0.000146	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MYC—kidney cancer	1.46e-06	0.000142	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PTGS2—kidney cancer	1.43e-06	0.000139	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MAPK1—kidney cancer	1.42e-06	0.000139	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PTGS2—kidney cancer	1.41e-06	0.000138	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PTEN—kidney cancer	1.35e-06	0.000132	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KRAS—kidney cancer	1.35e-06	0.000131	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PTEN—kidney cancer	1.32e-06	0.000129	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PTEN—kidney cancer	1.24e-06	0.000121	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CA—kidney cancer	1.24e-06	0.000121	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PTEN—kidney cancer	1.23e-06	0.00012	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PTGS2—kidney cancer	1.21e-06	0.000118	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TP53—kidney cancer	1.2e-06	0.000117	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PTEN—kidney cancer	1.05e-06	0.000103	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CA—kidney cancer	9.55e-07	9.32e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CA—kidney cancer	9.32e-07	9.09e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CA—kidney cancer	8.78e-07	8.57e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CA—kidney cancer	8.7e-07	8.5e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CA—kidney cancer	7.44e-07	7.26e-05	CbGpPWpGaD
